DCTHNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
DELCATH SYSTEMS, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$14.37+0.29 (+2.06%)
Close on Oct 19, 2026
- Market cap
- $571.37M
- P/E (TTM)
- 1437.0
- Dividend yield
- –
Share price
+$2.40 (+20.05%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
DELCATH SYSTEMS, INC. grew revenue 35.8% to $95.42M over the twelve months to Jun 30, 2026. Operating income fell 136.2% to -$1.81M, moving the operating margin from 7.1% to -1.9%. Free cash flow was $17.51M, up 352.7% from a year earlier.
Revenue
$95.42M
+35.8% vs. a year earlier
Operating income
-$1.81M
-136.2% vs. a year earlier
Free cash flow
$17.51M
+352.7% vs. a year earlier
EPS, diluted
$0.01
-80.0% vs. a year earlier
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $571.37M
- P/E ratio
- 1437.0
- Price to sales
- 5.99
- Price to book
- 4.72
- Dividend yield
- –
- Free cash flow yield
- 3.06%
Fundamentals
- Revenue
- $95.42M
- Net income
- $532.00K
- EPS, diluted
- $0.01
- Free cash flow
- $17.51M
- Book value per share
- $3.05
- Diluted shares
- 40M
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
$95.42M+35.8% YoY
Gross profit
$83.06M+37.7% YoY
Operating income
-$1.81M-136.2% YoY
Net income
$532.00K-76.2% YoY
EPS, diluted
$0.01-80.0% YoY
Free cash flow
$17.51M+352.7% YoY
Reported periodTrailing twelve months